Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 16, 2021 (5 years ago)

Penicillin V Potassium for Oral Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454

Affected NDCs 0093-4125-73 0093-4125-74

Compare with the code on your package — it is the most precise check available.

Drug: Penicillin Category: Antibiotic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Penicillin V Potassium
NDC 00093-4125
125 mg/5mL Powder, for Solution
Oral
Teva Pharmaceuticals USA, Inc. Rx
Recalling firm
Teva Pharmaceuticals USA
NDC code
00093-4125-73
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0294-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Penicillin recalls

See all
Class II · Moderate risk

Bicillin L-A

cGMP Deviations: Products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-0701-10 D-0373-2024

Other recalls by Teva Pharmaceuticals USA

All 2021 recalls